Fundz

Molecularmd Corp. reported raising $2.07 Million in an initial SEC Form D filing, from an offering of $2.07 Million

PRIVATEFeb 10, 2017

Amount Raised

$2.07 Million

$2.07 Million sold, per SEC Form D (first sale Feb 10, 2017)

Round Type

Seed

Blue BellBiotechnology

Quick answer

MOLECULARMD CORP. raised $2.07 Million in a Seed round, dated February 10, 2017. MOLECULARMD CORP. is based in Blue Bell, Pennsylvania, United States.

How much did MOLECULARMD CORP. raise?
MOLECULARMD CORP. raised $2.07 Million in a Seed round on February 10, 2017.
What does MOLECULARMD CORP. do?
MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
Where is MOLECULARMD CORP. based and how big is it?
MOLECULARMD CORP. is based in Blue Bell, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as MOLECULARMD CORP. that raised within 45 days of this round, from Fundz verified event records.

  • ProMIS Neurosciences raised $210K on March 27, 2017.
  • Breathe Technologies, Inc. raised $4.3M (Seed) on March 27, 2017.
  • RightSciences LLC raised $20K (Pre-Seed) on March 27, 2017.
  • CANCER GENETICS, INC raised $6M on March 27, 2017.
  • Avalyn raised $17M on March 24, 2017.
  • HydroCision raised $3M (Seed) on March 24, 2017.

Who to call at MOLECULARMD CORP., and when

A new round usually means MOLECULARMD CORP. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MOLECULARMD CORP. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MOLECULARMD CORP., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MOLECULARMD CORP.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MOLECULARMD CORP.

Location

1341 SW CUSTER DRIVE

Blue Bell, Pennsylvania, United States

About

MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MOLECULARMD CORP. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for MOLECULARMD CORP.'s next move

See what Strategic adds

MOLECULARMD CORP. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.